A Study to Learn How Safe BAY3283142 is When Taken as a Single Dose or as Multiple Doses in Healthy Chinese Participants

Clinical trial NCT06487845 · COMPLETED

Trial details

NCT number: NCT06487845
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Kidney Disease Non-proliferative Diabetic Retinopathy Healthy Volunteers

Start date: 2024-07-04
Primary completion: 2024-09-19
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.